Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Mar 3;16(3):e55436.
doi: 10.7759/cureus.55436. eCollection 2024 Mar.

Noise Pareidolia Test in Parkinson's Disease and Atypical Parkinsonian Syndromes: A Retrospective Study

Affiliations

Noise Pareidolia Test in Parkinson's Disease and Atypical Parkinsonian Syndromes: A Retrospective Study

Takuya Matsumoto et al. Cureus. .

Abstract

Introduction: Pareidolias, or visual misperceptions, are a non-motor symptom of Parkinson's disease (PD) with unclear pathophysiology. The noise pareidolia test (NPT) is a tool for screening pareidolias. The usefulness of the NPT in differentiating PD from atypical parkinsonian syndromes (APS) is also unknown.

Methods: We retrospectively investigated 74 patients with PD and 18 patients with APS who took the NPT. Correlations between the number of pareidolic responses, gray matter volume, and cerebral blood flow were also examined in the patients with PD.

Results: The median number of pareidolic responses in patients with PD and patients with APS was 0 (interquartile range (IQR): 0-3) and 0 (IQR: 0-1), respectively, and tended to be higher in patients with PD than in those with APS (p = 0.077). It was significantly higher in patients with PD who had hallucinations (2; IQR: 0-9) (p = 0.016). The area under the receiver operating characteristic curve for the number of pareidolic responses in the NPT was 0.62 when used to differentiate PD and APS, and the optimal cutoff number of pareidolic responses was 2/3. Sensitivity and specificity were 25.7% and 100%, respectively. In the PD group, the number of pareidolic responses was correlated with age (r = 0.27; p = 0.021) and the Frontal Assessment Battery (FAB) score (r = -0.34; p = 0.0099). Magnetic resonance imaging showed no significant correlation between the number of pareidolic responses and the volume of focal gray matter. On cerebral hypoperfusion mapping, the left parietal lobe had a significant correlation with the number of pareidolic responses (r = 0.35; p = 0.027).

Conclusion: The number of pareidolic responses in NPT was suggested to be useful as a red flag to rule out APS in differentiating PD from APS. In PD without dementia, the number of pareidolic responses was associated with reduced blood flow in the left parietal lobe.

Keywords: atypical parkinsonian syndrome; noise pareidolia test; pareidolia; parkinson’s disease; visual hallucination; visual misperception.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. Number of pareidolic responses on the noise pareidolia test in patients with PD and APS
The number of pareidolic responses tended to be higher (p = 0.077) and had a larger variance in PD than in APS. PD: Parkinson’s disease; APS: atypical parkinsonian syndrome
Figure 2
Figure 2. Correlation of age and FAB score with pareidolia in patients with PD
The pareidolic responses correlated with (a) age (r = 0.27; p = 0.021) and (b) FAB score (r = −0.34; p = 0.0099). FAB: Frontal Assessment Battery; PD: Parkinson’s disease
Figure 3
Figure 3. Correlation between pareidolia and left parietal lobe cerebral blood flow in patients with PD
a: Brain surface image on vbSEE; the left parietal lobe is highlighted according to Talairach’s classification; b: The scatter plots show the extent of decrease in cerebral blood flow in the left parietal lobe and the number of pareidolic responses. PD: Parkinson’s disease; vbSEE: voxel-based stereotactic extraction estimation; L: left

References

    1. The PRIAMO study: a multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson's disease. Barone P, Antonini A, Colosimo C, et al. Mov Disord. 2009;24:1641–1649. - PubMed
    1. Hallucinations in Parkinson's disease: prevalence, phenomenology and risk factors. Fénelon G, Mahieux F, Huon R, Ziégler M. Brain. 2000;123 ( Pt 4):733–745. - PubMed
    1. Visual symptoms in Parkinson's disease and Parkinson's disease dementia. Archibald NK, Clarke MP, Mosimann UP, Burn DJ. Mov Disord. 2011;26:2387–2395. - PubMed
    1. The progression of cognition, psychiatric symptoms, and functional abilities in dementia with Lewy bodies and Alzheimer disease. Stavitsky K, Brickman AM, Scarmeas N, et al. Arch Neurol. 2006;63:1450–1456. - PubMed
    1. Pareidolias: complex visual illusions in dementia with Lewy bodies. Uchiyama M, Nishio Y, Yokoi K, Hirayama K, Imamura T, Shimomura T, Mori E. Brain. 2012;135:2458–2469. - PMC - PubMed

LinkOut - more resources